| Nonnucleoside reverse transcriptase inhibitor resistance and the role of the second-generation agents J Adams, N Patel, N Mankaryous, M Tadros, CD Miller Annals of Pharmacotherapy 44 (1), 157-165, 2010 | 92 | 2010 |
| Pharmacology of HIV integrase inhibitors JL Adams, BN Greener, ADM Kashuba Current Opinion in HIV and AIDS 7 (5), 390-400, 2012 | 70 | 2012 |
| Dolutegravir pharmacokinetics in the genital tract and colorectum of HIV-negative men after single and multiple dosing BN Greener, KB Patterson, HMA Prince, CS Sykes, JL Adams, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 64 (1), 39-44, 2013 | 64 | 2013 |
| Formulation, pharmacokinetics and pharmacodynamics of topical microbicides JL Adams, ADM Kashuba Best practice & research Clinical obstetrics & gynaecology 26 (4), 451-462, 2012 | 62 | 2012 |
| Decreased tenofovir diphosphate concentrations in a transgender female cohort: implications for human immunodeficiency virus preexposure prophylaxis ML Cottrell, HMA Prince, AP Schauer, C Sykes, K Maffuid, A Poliseno, ... Clinical Infectious Diseases 69 (12), 2201-2204, 2019 | 55 | 2019 |
| Single and multiple dose pharmacokinetics of dolutegravir in the genital tract of HIV-negative women JL Adams, KB Patterson, HMA Prince, C Sykes, BN Greener, JB Dumond, ... Antiviral therapy 18 (8), 1005-1013, 2013 | 47 | 2013 |
| Tenofovir diphosphate and emtricitabine triphosphate concentrations in blood cells compared with isolated peripheral blood mononuclear cells: a new measure of antiretroviral … JL Adams, C Sykes, P Menezes, HMA Prince, KB Patterson, K Fransen, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 62 (3), 260-266, 2013 | 44 | 2013 |
| Pharmacokinetics of two common antiretroviral regimens in older HIV‐infected patients: a pilot study JB Dumond, JL Adams, HMA Prince, RL Kendrick, R Wang, SH Jennings, ... HIV medicine 14 (7), 401-409, 2013 | 34 | 2013 |
| Review of Real‐World Implementation Data on Emtricitabine‐Tenofovir Disoproxil Fumarate as HIV Pre‐exposure Prophylaxis in the United States JL Adams, K Shelley, MR Nicol Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 39 (4 …, 2019 | 27 | 2019 |
| HIV PrEP trials: the road to success MR Nicol, JL Adams, ADM Kashuba Clinical investigation 3 (3), 2013 | 27 | 2013 |
| A call to action: the role of antiretroviral stewardship in inpatient practice, a joint policy paper of the Infectious Diseases Society of America, HIV Medicine Association … DE Koren, KK Scarsi, EK Farmer, A Cha, JL Adams, NS Pandit, J Chang, ... Clinical Infectious Diseases 70 (11), 2241-2246, 2020 | 26 | 2020 |
| An update on HIV-1 protease inhibitor resistance. JD Baxter, WM Chasanov, JL Adams | 14 | 2016 |
| A single-center retrospective cohort analysis of maternal and infant outcomes in HIV-infected mothers treated with integrase inhibitors during pregnancy ML Mounce, L Pontiggia, JL Adams Infectious diseases and therapy 6, 531-544, 2017 | 10 | 2017 |
| Altered TDF/FTC pharmacology in a transgender female cohort: Implications for PrEP ML Cottrell, HM Prince, K Maffuid, A Poliseno, N White, C Sykes, ... AIDS 2018, 2018 | 9 | 2018 |
| Virological failure in two patients with HIV-1 RNA viral loads> 1,000,000 copies/ml initiated on elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate JL Adams, D Byrne, R Pepe, A Gray, JD Baxter Antiviral Therapy 21 (2), 175-180, 2016 | 6 | 2016 |
| 1062. Daptomycin/Ceftaroline in combination vs. vancomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteremia M Fox, K Zeqollari, G Lee, L Pontiggia, D Byrne, J Adams, M King, L Rose Open Forum Infectious Diseases 5 (Suppl 1), S318, 2018 | 5 | 2018 |
| Changes in neurocognitive assessment scores after initiating dolutegravir-versus elvitegravir-based antiretroviral therapy JL Adams, YC Choi, M West, L Pontiggia, J Baxter, J George AIDS care 33 (11), 1507-1513, 2021 | 3 | 2021 |
| Comparative effectiveness of antiretroviral drug classes for the treatment of HIV infection in patients with high viral loads: a multicentre retrospective cohort study JL Adams, M Murray, N Patel, MT Sawkin, RC Boardman, C Pham, ... HIV medicine 22 (1), 28-36, 2021 | 2 | 2021 |
| Pharmacotherapy of human immunodeficiency virus infection JL Adams, JB Dumond, ADM Kashuba Koda-Kimble and Young’s applied therapeutics: The clinical use of drugs …, 2013 | 1 | 2013 |
| Maternal and infant outcomes in HIV positive mothers treated with integrase inhibitors compared to guideline recommended protease inhibitor regimens M Mounce, J Adams, L Pontiggia PHARMACOTHERAPY 35 (11), E272-E273, 2015 | | 2015 |
